This technology is a diagnostic tool for acute concussion and other chronic neurodegenerative disorders that uses eye and head movement tracking.
Current diagnostic modalities for traumatic brain injury are imperfect, as they rely on self-reported symptoms, cognitive tests, and computerized screening questionnaires that are prone to bias due to language and education dependence. Tremor, an involuntary movement disorder, is a common manifestation of traumatic brain injury and neurodegenerative disorders. The current standard for diagnosing tremor associated with neurodegenerative disorders and concussion is limited to anatomical extremities, such as hand or forearm. There is currently no standard for use of quantitative measurement of tremor to specifically diagnose brain injury or neurodegeneration.
This technology employs quantitative methods to simultaneously measure abnormal eye and head movements. It can enable diagnosis of oculomotor and vestibular degeneration and can be used to determine the severity of brain injury or degeneration caused by concussions, tauopathies, and other neurodegenerative disorders.
This technology has been validated in a case-control study using human subjects with a history of brain injury.
Patent Pending
IR CU21135
Licensing Contact: Joan Martinez